找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Handbook of Acute Leukemia; Wolfgang Hiddemann Book 2016 Springer International Publishing Switzerland 2016 Leukemia.Acute leukemia.Hemato

[復(fù)制鏈接]
樓主: Disclose
11#
發(fā)表于 2025-3-23 11:04:08 | 只看該作者
Introduction,utic approach. Acute and chronic leukemias both arise from the malignant transformation of hematopoietic stem cells. According to the lineage from which this process originates myeloid and lymphoid leukemias are discriminated. The discrimination between acute and chronic leukemias is based on their
12#
發(fā)表于 2025-3-23 16:18:18 | 只看該作者
Therapeutic management of acute myeloid leukemia,be to cure the patient with intensive chemotherapy. However, there are two main reasons why clinicians should not follow this approach: firstly, intensive chemotherapy cannot be administered safely due to comorbidities (or patient refusal), and secondly, the patient will not benefit from intensive c
13#
發(fā)表于 2025-3-23 19:36:18 | 只看該作者
Therapeutic management of acute promyelocytic leukemia,) or polymerase chain reaction (PCR) (promyelocytic leukemia/retinoic acid receptor [PML-RAR+]) and should be performed in specialized centers with experience in APL treatment. The high cure rate of APL can only be realized when therapy is initiated as soon as possible and therefore diagnosis must a
14#
發(fā)表于 2025-3-23 22:39:08 | 只看該作者
Therapeutic management of acute lymphoblastic leukemia,rapy, and subsequent complications of therapy such as infections and toxicity. ALL therapy protocols represent the most complex protocols in oncology and treatment in experienced centers is strongly recommended.
15#
發(fā)表于 2025-3-24 05:34:54 | 只看該作者
16#
發(fā)表于 2025-3-24 08:59:27 | 只看該作者
Greek Masks and Hebrew Chameleons,be to cure the patient with intensive chemotherapy. However, there are two main reasons why clinicians should not follow this approach: firstly, intensive chemotherapy cannot be administered safely due to comorbidities (or patient refusal), and secondly, the patient will not benefit from intensive c
17#
發(fā)表于 2025-3-24 12:22:29 | 只看該作者
18#
發(fā)表于 2025-3-24 15:09:00 | 只看該作者
https://doi.org/10.1007/978-1-349-25599-3rapy, and subsequent complications of therapy such as infections and toxicity. ALL therapy protocols represent the most complex protocols in oncology and treatment in experienced centers is strongly recommended.
19#
發(fā)表于 2025-3-24 22:58:34 | 只看該作者
Wolfgang HiddemannA concise, practical guide that discusses both acute myeloid leukemia and acute lymphocytic leukemia against the backdrop of the latest therapeutic advances in the field.Written by internationally ren
20#
發(fā)表于 2025-3-24 23:40:28 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 15:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
建平县| 万山特区| 无为县| 巢湖市| 拉萨市| 巴林右旗| 宽城| 中山市| 柳林县| 无锡市| 彝良县| 临洮县| 仁寿县| 凌源市| 休宁县| 青海省| 尉氏县| 海兴县| 汤阴县| 和田市| 大同县| 安义县| 广安市| 辽宁省| 兴国县| 米林县| 兴安县| 峨山| 新巴尔虎右旗| 通海县| 安福县| 广丰县| 中山市| 门头沟区| 鄢陵县| 奉化市| 文山县| 抚顺县| 瑞昌市| 苏尼特左旗| 水城县|